Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,180.00
-3.00 (-0.25%)
Apr 28, 2026, 5:24 PM IDT
-4.53%
Market Cap 135.04M
Revenue (ttm) 300.99M
Net Income (ttm) -18.07M
Shares Out 11.41M
EPS (ttm) -1.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 387
Average Volume 1,267
Open 1,175.00
Previous Close 1,183.00
Day's Range 1,156.00 - 1,183.00
52-Week Range 1,044.00 - 1,444.00
Beta 0.16
RSI 49.14
Earnings Date May 29, 2026

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, sk... [Read more]

Sector Healthcare
Founded 1947
Employees 390
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.